c-Src-dependent EGF receptor transactivation contributes to ET-1-induced COX-2 expression in brain microvascular endothelial cells

[1]  M. Anand-Srivastava,et al.  Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR. , 2010, American journal of physiology. Heart and circulatory physiology.

[2]  H. Hsieh,et al.  Calmodulin kinase II-dependent transactivation of PDGF receptors mediates astrocytic MMP-9 expression and cell motility induced by lipoteichoic acid , 2010, Journal of Neuroinflammation.

[3]  H. Hsieh,et al.  EV71 induces COX‐2 expression via c‐Src/PDGFR/PI3K/Akt/p42/p44 MAPK/AP‐1 and NF‐κB in rat brain astrocytes , 2010, Journal of cellular physiology.

[4]  H. Hsieh,et al.  Endothelin‐1 enhances cell migration via matrix metalloproteinase‐9 up‐regulation in brain astrocytes , 2010, Journal of neurochemistry.

[5]  J. Seagrave,et al.  Vehicular Emissions Induce Vascular MMP-9 Expression and Activity Associated With Endothelin-1–Mediated Pathways , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Shuzhen Guo,et al.  Dysfunctional Cell-Cell Signaling in the Neurovascular Unit as a Paradigm for Central Nervous System Disease , 2009, Stroke.

[7]  J. Pernow,et al.  The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. , 2007, Cardiovascular research.

[8]  Y. Surh,et al.  KG‐135 Inhibits COX‐2 Expression by Blocking the Activation of JNK and AP‐1 in Phorbol Ester–Stimulated Human Breast Epithelial Cells , 2007, Annals of the New York Academy of Sciences.

[9]  A. Srivastava,et al.  Endothelin-1-induced signaling pathways in vascular smooth muscle cells. , 2007, Current vascular pharmacology.

[10]  J. K. Kundu,et al.  Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. , 2006, Biochemical pharmacology.

[11]  R. McCarron,et al.  Endothelial-mediated regulation of cerebral microcirculation. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[12]  J. Jeong,et al.  Activation of p38 MAPK is involved in endothelin-1-stimulated COX-2 expression in cultured Feline esophageal smooth muscle cells. , 2006, Molecules and cells.

[13]  H. Hsieh,et al.  Sphingosine‐1‐phosphate induces COX‐2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells , 2006, Journal of cellular physiology.

[14]  M. Montagnani,et al.  Endothelin-1: the yin and yang on vascular function. , 2006, Current medicinal chemistry.

[15]  T. Carter,et al.  Cyclooxygenase-2 Induction and Prostacyclin Release by Protease-activated Receptors in Endothelial Cells Require Cooperation between Mitogen-activated Protein Kinase and NF-κB Pathways* , 2006, Journal of Biological Chemistry.

[16]  Yen-Ling Chen,et al.  Reactive Oxygen Species Generation Is Involved in Epidermal Growth Factor Receptor Transactivation through the Transient Oxidization of Src Homology 2-Containing Tyrosine Phosphatase in Endothelin-1 Signaling Pathway in Rat Cardiac Fibroblasts , 2006, Molecular Pharmacology.

[17]  H. Hsieh,et al.  Bradykinin‐induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3‐K/Akt in vascular smooth muscle cells , 2005, Journal of cellular physiology.

[18]  A. Zeiher,et al.  Endothelial Function: Cardiac Events , 2005, Circulation.

[19]  J. Cayuela,et al.  Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia , 2005, The Journal of pathology.

[20]  F. Spinella,et al.  Endothelin-1 Stimulates Cyclooxygenase-2 Expression in Ovarian Cancer Cells Through Multiple Signaling Pathways: Evidence for Involvement of Transactivation of the Epidermal Growth Factor Receptor , 2004, Journal of cardiovascular pharmacology.

[21]  L. Minghetti.  Cyclooxygenase‐2 (COX‐2) in Inflammatory and Degenerative Brain Diseases , 2004, Journal of neuropathology and experimental neurology.

[22]  R. Ji.  Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases. , 2004, Current drug targets. Inflammation and allergy.

[23]  D. Bleich,et al.  Transcriptional Regulation of Cyclooxygenase-2 Gene in Pancreatic β-Cells* , 2004, Journal of Biological Chemistry.

[24]  C. Iadecola.  Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[25]  Pasko Rakic,et al.  JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Y. Song,et al.  Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. , 2003, Carcinogenesis.

[27]  D. Bleich,et al.  Transcriptional regulation of cyclooxygenase-2 gene in pancreatic beta-cells. , 2004, The Journal of biological chemistry.

[28]  M. Foschi,et al.  Alterations in Subcellular Localization of p38 MAPK Potentiates Endothelin-stimulated COX-2 Expression in Glomerular Mesangial Cells* , 2003, Journal of Biological Chemistry.

[29]  A. Knox,et al.  Transcriptional Regulation of Cyclooxygenase 2 by Bradykinin and Interleukin-1β in Human Airway Smooth Muscle Cells: Involvement of Different Promoter Elements, Transcription Factors, and Histone H4 Acetylation , 2003, Molecular and Cellular Biology.

[30]  R. Wetzker,et al.  Transactivation joins multiple tracks to the ERK/MAPK cascade , 2003, Nature Reviews Molecular Cell Biology.

[31]  B. Levy,et al.  Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  C. Faverdin,et al.  Evidence for ERK1/2 activation by thrombin that is independent of EGFR transactivation. , 2003, American journal of physiology. Heart and circulatory physiology.

[33]  B. Meyrick,et al.  Cyclooxygenase is regulated by ET-1 and MAPKs in peripheral lung microvascular smooth muscle cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[34]  P. Dennis,et al.  Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt. , 2003, Journal of the American Chemical Society.

[35]  G. Reiser,et al.  Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. , 2002, American journal of physiology. Cell physiology.

[36]  T. Tanabe,et al.  Cyclooxygenase isozymes and their gene structures and expression. , 2002, Prostaglandins & other lipid mediators.

[37]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[38]  C. Liebmann,et al.  Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. , 2001, Cellular signalling.

[39]  R. Zidovetzki,et al.  Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures , 2001, Journal of Neuroimmunology.

[40]  P. Lewczuk,et al.  Role of the astrocytic ETB receptor in the regulation of extracellular endothelin‐1 during hypoxia , 2001, Glia.

[41]  J. Abraham,et al.  Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. , 2000, Circulation research.

[42]  R. Garavito,et al.  Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.

[43]  R. DuBois,et al.  The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.

[44]  A. Ullrich,et al.  The EGF receptor as central transducer of heterologous signalling systems. , 1999, Trends in pharmacological sciences.

[45]  M. Freissmuth,et al.  G protein antagonists. , 1999, Trends in pharmacological sciences.

[46]  Chul-hak Yang,et al.  Suppression of AP-1 Activity by Tanshinone and Cancer Cell Growth Inhibition , 1999 .

[47]  A. Ullrich,et al.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.

[48]  R. Zidovetzki,et al.  Endothelin-1-induced interleukin-8 production in human brain-derived endothelial cells is mediated by the protein kinase C and protein tyrosine kinase pathways. , 1999, Blood.

[49]  S. Fischer,et al.  Transcriptional Regulation of Cyclooxygenase-2 in Mouse Skin Carcinoma Cells , 1998, The Journal of Biological Chemistry.

[50]  R. Lefkowitz,et al.  Gβγ Subunits Mediate Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor , 1997, The Journal of Biological Chemistry.

[51]  R. Lefkowitz,et al.  Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. , 1997, The Journal of biological chemistry.

[52]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[53]  B. Levin.  Book Review Cancer Prevention and Control (Basic and Clinical Oncology.) Edited by Peter Greenwald, Barnett S. Kramer, and Douglas L. Weed. 803 pp. New York, Marcel Dekker, 1995. $195. 0-8247-9258-0 , 1995 .

[54]  E. Levin.  Mechanisms of disease : endothelins , 1995 .

[55]  M. Polokoff,et al.  Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. , 1994, Pharmacological reviews.

[56]  C. Marshall,et al.  MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. , 1994, Current opinion in genetics & development.

[57]  W. Herman,et al.  Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. Cross-talk between G protein-coupled receptors and pp60c-src. , 1993, The Journal of biological chemistry.

[58]  T. Higashijima,et al.  G protein antagonists. A novel hydrophobic peptide competes with receptor for G protein binding. , 1992, The Journal of biological chemistry.

[59]  S. Nakanishi,et al.  Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. , 1992, The Journal of biological chemistry.

[60]  G. Rubanyi,et al.  Endothelins , 1991, The Lancet.

[61]  S. Nakanishi,et al.  Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.